1. Home
  2. IPSC vs ELVA Comparison

IPSC vs ELVA Comparison

Compare IPSC & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.27

Market Cap

407.6M

Sector

Health Care

ML Signal

HOLD

Logo Electrovaya Inc.

ELVA

Electrovaya Inc.

HOLD

Current Price

$10.83

Market Cap

466.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
ELVA
Founded
2019
1996
Country
United States
Canada
Employees
78
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.6M
466.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IPSC
ELVA
Price
$2.27
$10.83
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$4.25
$14.00
AVG Volume (30 Days)
644.7K
449.6K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
91.30
N/A
EPS
N/A
N/A
Revenue
$109,164,000.00
N/A
Revenue This Year
N/A
$34.68
Revenue Next Year
N/A
$51.48
P/E Ratio
N/A
$78.51
Revenue Growth
1556.76
N/A
52 Week Low
$0.44
$2.98
52 Week High
$2.97
$11.88

Technical Indicators

Market Signals
Indicator
IPSC
ELVA
Relative Strength Index (RSI) 49.15 57.76
Support Level $2.15 $7.10
Resistance Level $2.41 $11.41
Average True Range (ATR) 0.13 0.89
MACD -0.01 -0.04
Stochastic Oscillator 56.67 70.34

Price Performance

Historical Comparison
IPSC
ELVA

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

About ELVA Electrovaya Inc.

Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.

Share on Social Networks: